Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Tax Rate (2018 - 2025)

Akebia Therapeutics (AKBA) has disclosed Tax Rate for 3 consecutive years, with 53.25% as the latest value for Q3 2025.

  • On a quarterly basis, Tax Rate changed N/A to 53.25% in Q3 2025 year-over-year; TTM through Sep 2025 was 4.02%, a N/A change, with the full-year FY2025 number at 43.64%, changed N/A from a year prior.
  • Tax Rate was 53.25% for Q3 2025 at Akebia Therapeutics, up from 1.82% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 53.25% in Q3 2025 to a low of 53.25% in Q3 2025.